Archives

by in
Entry Author Date Location
CytomX Snags $25M From Pfizer to Make Souped-Up Antibodies 06/06/13 San Francisco
Biodesix’s VeriStrat Test for Cancer Treatment Passes Phase 3 Trial 06/03/13 Boulder/Denver
Merck Joins Bristol, Genentech in Great Cancer Immunotherapy Race 06/02/13 New York
Plexxikon Leadership Duo, Peter Hirth and Kathy Glaub, Exit Daiichi 05/31/13 San Francisco
East Coast Life Sciences Roundup: Epizyme, Alkermes, Ophthotech, & More 05/31/13 Boston
Epizyme Prices IPO at $15 Per Share, Begins Trading Friday 05/30/13 Boston
There’s Less Pie in the Sky as Wireless Health Gets Connected 05/30/13 San Diego
Oncothyreon Nabs $10M, Pays $10M, For Array Biopharma Cancer Drug 05/30/13 Seattle
Assigning Credit and Blame to Biopharma R&D Chiefs 05/29/13 Seattle
San Diego Life Sciences Roundup: Topera, Afraxis, Trovagene, & More 05/03/13 San Diego
Aveo’s Stock Plunges As Day of Reckoning Nears For Cancer Drug 04/30/13 Boston
Six Reasons Why Illumina Has Nothing to Fear from Thermo/Life 04/29/13 National
San Diego Life Sciences Roundup: Receptos IPO, Isis, Versant, & More 04/12/13 San Diego
Roche & Isis Join Forces on Antisense Drug for Huntington’s Disease 04/08/13 San Diego
Sequencing Seattle: An Idea for the Future of the Northwest 04/03/13 Seattle
Biotech VCs Aren’t Lemmings Anymore. They’re Lone Rangers 03/25/13 National
AstraZeneca Shells Out $240M Upfront For Moderna mRNA Drugs 03/21/13 Boston
Finding Parallels in Baseball and Drug Development 03/01/13 Seattle
Genentech, ImmunoGen Win FDA OK for Souped-Up Breast Cancer Drug 02/22/13 San Francisco
Adimab Grows Up, Looks to Pay Off the VCs In Unusual Way 02/22/13 Boston
Shedding Baggage, Alnylam Turns a Corner 02/21/13 Boston
The Reimbursed Personal Genome—-Five Years Away? 02/19/13 New York
San Diego Life Sciences Roundup: RQx Pharma, Elcelyx, Lux, & More 02/15/13 San Diego
In VC ‘Hat Trick’ for San Diego’s Avalon, RQx Inks Genentech Deal 02/12/13 San Diego
Infinity Pharmaceuticals Bounces Back To Compete in Crowded Field 02/08/13 Boston
San Diego Life Sciences Roundup: Isis, Afraxis, Organovo, & More 01/31/13 San Diego
Companion Diagnostics for Cancer Drugs Advancing Personalized Medicine 01/31/13 Boston
Afraxis Licenses its Drug Compounds to Roche Subsidiary Genentech 01/29/13 San Diego
San Diego Life Sciences Roundup: Illumina, Santarus, Accelrys, & More 01/18/13 San Diego
Roche Recruits Sanford-Burnham CEO John Reed to Head Pharma Research 01/15/13 San Diego
Page 1 of 12 next page »

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.